Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

CircuLite: NIH will grant CircuLite up to $3.7 million in a Fast-Track Phase I-II Small Business Innovation Research Grant to develop a pediatric circulatory assist device based on the same technology as the firm's Synergy Pocket Micro-pump, a small impeller-driven ventricular assist device about the size of a AA battery. Saddle Brook, N.J.-based CircuLite will collaborate with the University of Maryland School of Medicine on the project. CircuLite is currently conducting a European trial of Synergy Pocket Micro-pump (1"The Gray Sheet" Sept. 17, 2007)
Advertisement

Related Content

Cyberonics Q1 Epilepsy Sales Up 16%; Firm Continues To Ramp Up R&D Spend
Cyberonics Q1 Epilepsy Sales Up 16%; Firm Continues To Ramp Up R&D Spend
Former ODE Staffers Dispute Claims Of Office Corruption And Coercion
CircuLite Aims To Transform HF Treatment With Miniature Blood Pump
CircuLite Aims To Transform HF Treatment With Miniature Blood Pump

Topics

Advertisement
UsernamePublicRestriction

Register

MT027750

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel